Нарушение адгезионной активности как форма эндотелиальной дисфункции
https://doi.org/10.18705/2311-4495-2014-0-3-5-15
Аннотация
В статье обсуждаются основные патофизиологические механизмы адгезионной формы эндотелиальной дисфункции и пути фармакологической коррекции нарушений адгезионной активности эндотелия при атеросклерозе.
Об авторах
Николай Николаевич Петрищев
ФГБУ «Федеральный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России
Россия
Россия
Любовь Васильевна Васина
ФГБУ «Федеральный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России
Россия
Россия
Список литературы
1. Петрищев Н.Н., Васина Л.В., Власов Т.Д. и др. Типовые формы дисфункции эндотелия // Клиниколабораторный консилиум. - 2007. - № 18. - С. 31-35.
2. Gerrity R.G. The role of the monocyte in atherogenesis // Am. J. Pathol. - 1981. - Vol. 103. - P. 181-190.
3. O’Brien K.D., Allen M.D., McDonald T.O. et al. Vascular cell endothelial molecule-1 is expressed in human coronary atherosclerotic plaques // J. Clin. Invest. - 1993. - Vol. 92. - P. 945-951.
4. Rohde L.E., Lee R.T., Rivero J. et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis // Arterioscler. Thromb. Vasc. Biol. - 1998. - Vol. 18. - P. 1765-1770.
5. Jang Y., Lincoff A.M., Plow E.F. et al. Cell adhesion molecules in coronary artery disease // J. Am. Coll. Cardiol. - 1994. - Vol. 24. - P. 1591-1601.
6. Белоцкий С.М., Авталион Р.Р. Воспаление. Мобилизация клеток и клинические эффекты. - М.: Изд-во БИНОМ, 2008. - 240 с.
7. Фрейдлин И.С. Иммунная система и ее дефекты: Руководство для врачей. - СПб, 1998. - 113 с.
8. Фрейдлин И.С., Старикова Э.А. Эндотелиальная клетка как мишень действия бактерий и их компонентов // Медицинский академический журнал. - 2010. - № 4. - С. 95-106.
9. Carlos T.M. Leukocyte-endothelial adhesion molecules // Blood. - 1994. - Vol. 84. - P. 2068-2101.
10. Ройт А., Бростофф Дж., Мейл Д.М. Иммунология. - М.: Мир, 2000. - 592 с.
11. McEver R.P. Selectins: lectins that initiate cell adhesion under flow // Curr. Opin. Cell Biol. - 2002. - Vol. 14. - P. 581-586.
12. Khew-Goodall Y., Butcher C.M., Litwin M.S. et al. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin 3 // Blood. - 1996. - Vol. 87. - P. 1432-1438.
13. Park E.Y., Smith M.J., Stropp E.S. et al. Comparison of PSGL-1 microbead and neutrophil rolling: microvillus elongation stabilizes P-selectin bond clusters // Biophys. J. - 2002. - Vol. 82. - P. 1835-1847.
14. Leenwenberg J.F.M., Smeets E.F, Neefjes J.J. et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro // Immunology. - 1992. - Vol. 77. - P. 543-549.
15. Burdick M.M., Bochner B.S., Collins B.E. et al. Glycolipids support E-selectin-specific strong cell tethering under flow // Biochem. Biophys. Res. Commun. - 2001. - Vol. 284. - P. 42-49.
16. Plow E.F., Haas T.A., Zhang L. et al. Ligand binding to integrins // J. Biol. Chem. - 2000. - Vol. 275 (29). - P. 21785-21788.
17. Juliano R.L. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members // Ann. Rev. Pharmacol. Toxicol. - 2002. - Vol. 42. - P. 283-323.
18. Vestweber D. ICAM-2: regulator of leukocyte migration and angiogеnеsis // Blood. - 2005. - Vol. 106, № 5. - P. 1510-1511.
19. Newman P.J., Newman D.K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology // Arterioscler. Thromb. Vasc. Biol. - 2003. - Vol. 23. - P. 953-964.
20. Carmeliet P., Lampugnani M.-G., Moons L. et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis // Cell. - 1999. - Vol. 98. - P. 147-157.
21. Gory-Faure S., Prandini M.H., Pointu H. et al. Role of vascular endothelial-cadherin in vascular morphogenesis // Development. - 1999. - Vol. 126. - P. 2093-2102.
22. Rohlena J., Volger O.L., van Buul J.D. et al. Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion // Cardiovasc. Res. - 2009. - Vol. 81, № 1. - P. 187-196.
23. Mehta J.L., Nichols W.W., Mehta P. Neutrophils as potential participants in acute myocardial ischemia // J. Am. Coll. Cardiol. - 1988. - Vol. 11. - P. 1309-1316.
24. Cipollone F., Marini M., Fazia M. et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty // Arterioscler. Thromb. Vasc. Biol. - 2001. - Vol. 21. - P. 327-334.
25. Ikeda H., Nakayama H., Oda T. et al. Neutrophil activation after percutaneous transluminal coronary angioplasty // Am. Heart J. - 1994. - Vol. 128. - P. 1091-1098.
26. Chen L.Y., Nichols W.W., Hendricks J.B. et al. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in dogs // Cardiovasc. Res. - 1994. - Vol. 28, № 9. - P. 1414-1422.
27. Lefer D.J., Shandelya S.M.L., Serrano C.V et al. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury // Circulation. - 1993. - Vol. 8. - P. 779-787.
28. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury // Cardiovasc. Res. - 1999. - Vol. 43, № 4. - P. 860-878.
29. Kodaki S., Sawa Y., Sano T. et al. Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury // Circulat. Res. - Vol. 84, № 5. - P. 516-524.
30. Lefer A.M., Campbell B., Scalia R. // Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion. Role of selectins // Circulation. - 1998. - Vol. 98. - P. 1322-1328.
31. Tojo S.J., Yokota S., Koike H. et al. Reduction of rat myocardial ischemia and reperfusion injury by sialyl Lewis Х oligosaccharide and anti-rat P-selectin antibodies // Gly-cobiology. - 1996. - Vol. 6. - P. 463-469.
32. Gumina R.J., Schultz J. E., Yao Z. Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury // Circulation. - 1996. - Vol. 94. - P. 3327-3333.
33. Myers D.D., Farris D.M., Hawley A.E. et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis // J. Surg. Res. - 2002. - Vol. 108. - P. 212-221.
34. Myers D.D., HawleyA.E., Farris D.M. et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis // J. Vasc. Surg. - 2003. - Vol. 38, № 5. - P. 1075-1089.
35. Walenga J.M., Jeske W.P., Messmore H.L. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia // J. Thromb. Thrombolysis. - 2000. - Vol. 10, Suppl. 1. - P. 13-20.
36. Mesri M., Altieri D.C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway // J. Biol. Chem. - 1999. - Vol. 274. - P. 23111-23118.
37. Sabatier F., Roux V., Anfosso F. et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity // Blood. - 2002. - Vol. 99. - P. 3962-3970.
38. Ham A.S., Goetz D.J., Klibanov A.L. et al. Microparticle adhesive dynamics and rolling mediated by selectin-specific antibodies under flow // Biotechnol. Bioeng. - 2007. - Vol. 96, № 3. - P. 596-607.
39. Norman K.E., Katopodis A.G., Thoma G. et al. P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo // Blood. - 2000. - Vol. 96, № 10. - P. 3585-3591.
40. Миронов П.И., Альес В.Ф. Молекулярные аспекты системного воспалительного ответа при сепсисе // Новости науки и техники. Информ. сб. Серия: Медицина. Вып. Реаниматол. и интенсив. терапия. Анестезиол. / ВИНИТИ. - 2000. - № 4. - С. 1-9.
41. Молчанова Л.В., Мороз В.В. Молекулярные аспекты полиорганной недостаточности: Молекулы адгезии (Обзор литературы) // Новости науки и техники. Информ. сб. Серия: Медицина. Вып. Реаниматол. и интенсив. терапия. Анестезиол. / ВИНИТИ. - 1999. - № 2. - С. 10-17.
42. Nakashima Y., Wight T.N., Sueishi K. Early atherosclerosis in humans: role of diffuse intimal thickening and extravascular matrix proteoglycans // Cardiovasc. Res. - 2008. - Vol. 79. - P. 14-23.
43. Bourdillon M.C., Poston R.N., Covacho C. et al. ICAM-1 deficiency reduces atherosclerotic lesions in doubleknockout mice (ApoE (-/-) / ICAM-1(-/-) fed a fat or a chow diet // Arterioscler. Thromb Vasc. Biol. - 2000. - Vol. 20, № 12. - P. 2630-2635.
44. Collins R.G., Velji R., Guevara N.V. et al. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice // J. Exp. Med. - 2000. - Vol. 191. - P.189-194.
45. Dong Z.M., Brown A.A., Wagner D.D. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice // Circulation. - 2000. - Vol. 101. - P. 2290-2295.
46. Johnson R.C., Chapman S.M., Dong Z.M. et al. Absence of P-selectin delays fatty streak formation in mice // J. Clin. Invest. - 1997. - Vol. 99. - P. 1037-1043.
47. Cybulsky M.I., Liyama K., Dong Z.M. et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis // J. Clin. Invest. - 2001. - Vol. 107, № 10. - P. 1255-1262.
48. Patel S.S., Thiagarajan R., Willerson J.T. et al. Inhibition of a4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in apoE-deficient mice // Circulation. - 1998. - Vol. 97. - P. 75-81.
49. Ramos C.L., Huo Y., Jung U. et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice // Circ. Res. - 1999. - Vol. 84. - P. 1237-1244.
50. Nakashima Y., Raines E.W., Plump A.S. et al. Up-regulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse // Arterioscler. Thromb. Vasc. Biol. - 1998. - Vol. 18. - P. 842-851.
51. Nageh M.F., Sandberg E.T., Marotti K.R. et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice // Arterioscler. Thromb. Vasc. Biol. - 1997. - Vol. 17. - P. 1517-1520.
52. Shih P.T., Brennan M.L., Vora D.K. et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet // Circ. Res. - 1999. - Vol. 84. - P. 345-351.
53. Oguchi S., Dimayuga P., Zhu J. et al. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice // Arterioscler. Thromb. Vasc. Biol. - 2000. - Vol. 20, № 12. - P. 1729-1736.
54. O’Brien K.D., Allen M.D., McDonald T.O. et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis // J. Clin. Invest. - 1993. - Vol. 92. - P. 945-951.
55. Волков В.И., Серик С.А. Провоспалительные цитокины и растворимая молекула межклеточной адгезии - 1 при ишемической болезни сердца // Кардиология. - 2002. - № 9. - С. 12-16.
56. Rattazzi M., Puato M., Faggin E. et al. New markers of accelerated atherosclerosis in end-stage renal disease // J. Nephrol. - 2003. - Vol. 16. - P. 11-20.
57. MalikI.S., Hascard D.O. Soluble adhesion molecules in ishaemic heart disease // Eur. Heart. J. - 1999. - Vol. 20, № 14. - P. 990-991.
58. Morisaki N., Saito I., Tamura K. et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in patients with hypercholesterinemia and ischemic heart disease // Atherosclerosis. - 1997. - Vol. 131. - P. 43-48.
59. Blankenberg S., Rupprecht H.J., Bickel C. et al. Circulating cell adhesion molecules and death in patients with coronary artery disease // Circulation. - 2001. - Vol. 104. - P. 1336-1341.
60. Kerner T., Ahlers O., Reschreiter H. et al. Adhesion molecules in different treatments of acute myocardial infarction // Critical Care. - 2001. - Vol. 5, № 3. - P. 145-150.
61. Васина Л.В. Маркеры апоптоза и дисфункция эндотелия при остром коронарном синдроме // Регионарное кровообращение и микроциркуляция. - 2004. - № 4 (12). - С. 5-10.
62. Ghaisas N.K., Shahi C.N., Goggins M. et al. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina // Am. J. Card. - 1997. - Vol. 80. - P. 617-619.
63. Shimomura H., Ogawa H., Arai H. et al. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction // Am. J. Card. - 1998. - Vol. 81, № 4. - P. 397-400.
64. Blann A.D., Lip G.Y. Cell adhesion molecules in cardiovascular disease and its risk factors - what can soluble levels tell us? // J. Clin. Endocrinol. Metab. - 2000. - Vol. 85, № 5. - P. 1745-1747.
65. Hwang S.-J., Ballantyne S.M., Sharrett R. et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) study // Circulation. - 1997. - Vol. 96. - P. 4219-4225.
66. Васина Л.В. Клеточные и гуморальные маркеры апоптоза при остром коронарном синдроме в сочетании с гипертонической болезнью // Артериальная гипертензия. - 2008. - Т. 14, № 4. - С. 332-335.
67. Lemos J.A., Hennekens C.H., Ridker P.M. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk // J. Am. Coll. Cardiol. - 2000. - Vol. 36. - P. 423-426.
68. Milvihill N.T., Foley J.B., Murphy R.T. et al. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules // Heart. - 2001. - Vol. 85. - P. 623-627.
69. Ridker P.M., Buring J.E., Rifai N. Soluble P-selectin and the risk of future cardiovascular events // Circulation. - 2001. - Vol. 103. - P. 491-496.
70. O’Malley T., Ludlam C.A., Riemermsa R.A. et al. Early increase in levels of soluble inter-cellular adhesion molecule -1; potential risk factor for the acute coronary syndromes // Eur. Heart J. - 2001. - Vol. 22. - P. 1226-1234.
71. Mulvihill N., Foley G.В., Ghaisas N. et al. Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarction // Am. J. Card. - 1999. - Vol. 83. - P. 1265-1267.
72. Ridker P.M., Hennekens C.H., Johnson B.R. et al. Plasma concentration of soluble intercellular adhesion molecule - 1 and risks of future myocardial infarction in apparently healthy men // Lancet. - 1998. - Vol. 351. - P. 88-92.
73. Gurbel P.A., Kereiakes D.J., Dalesandro M.R. et al. Role of soluble and platelet bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department // Am. Heart J. - 2000. - № 2, Р. 11. - P. 320-328.
74. Baudin B., Berard M., Carrier J.L. et al. Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells // Endothelium. - 1997. - Vol. 5, № 1. - P. 73-84.
75. Gebb S., Stevens T. On lung endothelial cell heterogeneity // Microvasc. Res. - 2004. - Vol. 68. - P. 1-12.
76. Ochoa C.D., Wu S., Stevens T. New developments in lung endothelial heterogeneity: von Willebrand factor, P-selectin, and the Weibel-Palade body // Semin. Thromb. Hemost. - 2010. - Vol. 36, № 3. - P. 301-308.
77. Brutsaert D.L., Fransen P., Andries L.J. et al. Cardiac endothelium and myocardial function // Cardiovasc. Res. - 1998. - Vol. 38. - P. 281-290.
78. Вызова Т.В. Молекулы клеточной адгезии в культуре эндотелиальных клеток аорты человека: дис.. канд. биол. наук. - М., 1995. - С. 3-7.
79. Hauser I.A., Johnson D.R., Madri J.A. Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion // J. Immunol. - 1993. - Vol. 151, № 10. - P. 5172-5185.
80. Davenpeck K.L., Gauthier T.W., Lefer A.M. Inhibition of endothelial nitric oxide promotes P-selectin expression and actions in the rat microcirculation // Gastroenterology. - 1994. - Vol. 107. - P. 1050-1058.
81. Gauthier T.W., Scalia R., Murohara T. et al. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia // Arterioscler. Thromb. Vasc. Biol. - 1995. - Vol. 15. - P. 1652-1659.
82. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells // Circulation. - 2000. - Vol. 102. - P. 2165-2168.
83. Pasceri V., Chang J.S., Willerson J.T. et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs // Circulation. - 2001. - Vol. 103. - P. 2531-2534.
84. Yoshida M., Sawada T., Ishii H. et al. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism // Arterioscler. Thromb. Vasc. Biol. - 2001. - Vol. 21, № 7. - P. 1165-1171.
85. Ikeda U., Ito T., Shimada K. Statins and C-reactive protein // Lancet. - 1999. - Vol. 353, № 9160. - P. 12741275.
86. Sparrow C.P., Burton C.A., Hernandez M. et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering // Arterioscler. Thromb. Vasc. Biol. - 2001. - Vol. 21. - Р. 115-121.
87. Cominacini L., Pasini A.F., Pastorino A.M. et al. Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells // J. Hypertens. - 1999. - Vol. 17, № 12, Pt. 2. - P. 1837-1841.
88. Несукай Е.Г. Зофеноприл: ингибитор ангиотензинпревращающего фермента с особыми свойствами // Украинский кардиологический журнал. - 2013. - № 2. - С. 97-102.
89. Cominacini L., Pasini A., Garbin U. et al. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species // Am. J. Hypertens. - 2002. - Vol. 15, № 10, Pt. 1. - P. 891-895.
Рецензия
Для цитирования:
Петрищев Н.Н., Васина Л.В. Нарушение адгезионной активности как форма эндотелиальной дисфункции. Трансляционная медицина. 2014;(3):5-15. https://doi.org/10.18705/2311-4495-2014-0-3-5-15
For citation:
Petrishchev N.N., Vasina L.V. DISORDERS OF ADHESIVE ACTIVITY AS A FORM OF ENDOTHELIAL DYSFUNCTION. Translational Medicine. 2014;(3):5-15. (In Russ.) https://doi.org/10.18705/2311-4495-2014-0-3-5-15
Просмотров:
724
Послать статью по эл. почте 